Your browser doesn't support javascript.
loading
Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
Liao, S; Cai, C; Huo, F-M; Wu, J-N; Kong, C-C; Huang, H-R; Xu, S-F; Sun, Z-G.
Afiliación
  • Liao S; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Cai C; Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Huo FM; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Wu JN; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Kong CC; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Huang HR; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Xu SF; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
  • Sun ZG; National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.
Int J Tuberc Lung Dis ; 21(9): 990-995, 2017 09 01.
Article en En | MEDLINE | ID: mdl-28826447
ABSTRACT

OBJECTIVE:

To describe the trends in prevalence of drug-resistant tuberculosis (TB) among in-patients in Beijing Chest Hospital, Beijing, China, using a 10-year retrospective study.

DESIGN:

From 2005 to 2014, 18 310 in-patients with TB were recruited for the study, most of whom were referrals; no distinction was made between new and previously treated cases. Drug susceptibility testing (DST) was performed in culture-positive cases using the proportion method to determine multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). Risk factors associated with drug resistance were identified.

RESULTS:

A total of 5141 (28.0%) samples were culture-positive. DST results showed that 860 (16.7%) cases were MDR-TB and 176 (3.4%) were XDR-TB. MDR-TB and XDR-TB were detected in respectively 21.2% and 12.5% of new cases. The rate of MDR-TB and XDR-TB gradually increased from 2005, with MDR-TB reaching a peak in 2008 and XDR-TB in 2009. These data closely mirror national survey data on this region, patient age and occupation.

CONCLUSION:

Trends in MDR-TB and XDR-TB prevalence during the past decade and their inflection points were determined, which complemented reports from previous national surveys. This information is useful for fighting TB in China.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Tuberculosis Extensivamente Resistente a Drogas Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Tuberculosis Extensivamente Resistente a Drogas Tipo de estudio: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2017 Tipo del documento: Article País de afiliación: China